Skip to main content

Healthcare Predictive Analytics Market is Growing at a Healthy CAGR of 29.3% During Forecast to 2023

Overview:
The market is also going to benefit from rising prevalence of chronic diseases and demand for personalized medicines. However, the cost is sometimes too high for patients from the developing countries, which can restrain the growth.
The global Healthcare Predictive Analytics Market Share is all set to gain from various factors like increasing healthcare funding, better understanding of technologies, simplified inclusion of various methods, support from various end users, and others. Market Research Future (MRFR) makes a predictive analysis of the market where it reveals that the market can fetch a 29.3% CAGR during the forecast period covering a time frame of 2018-2023.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/7549
Competitive Landscape:
Verisk Analytics, Inc., IBM, Cerner Corporation, Oracle, Allscripts, Optum, Inc., McKesson Corporation, SAS, Health Catalyst, MedeAnalytics, Inc., Wipro Limited, Inovalon, CitiusTech, Inc., SCIO Health Analytics, Verscend Technologies, Inc, and VitreosHealth.

Segmentation:
  • The global study on the healthcare predictive analytics market includes component, application, and end user as segments. The detailed analysis of these segments reveals various factors that can influence the market and its movement in the coming years.
  • By component, the healthcare predictive analytics market can be segmented into software, services, and hardware. The software sector would benefit significantly from the growing digitalization.
  • By application, the report on the healthcare predictive analytics market can be segmented into financial, population health, operations management, and clinical. The operations management segment includes workforce planning and scheduling, inpatient scheduling, demand forecasting, and outpatient scheduling. The financial segment comprises fraud detection, revenue cycle management, and others. The population health segment includes patient engagement, population therapy management, population risk management, and others. The clinical segment encompasses patient care enhancement, clinical outcome analysis, quality benchmarking, and management.
  • By end user, the study on the healthcare predictive analytics market reveals providers, payers, and others.
Regional Analysis:
The market in North America is touted to be boosted by superlative infrastructure, high rate of technological inclusions, and better funding scopes. These will help the regional healthcare market initiate such changes and provide better patient care.  The healthcare predictive analytics market in APAC is expected to benefit from the developments in structure as several emerging nations are pumping in finances to establish better healthcare system.
Industry News:
In April 2020, Philips and UK HealthCare, recently announced that they will be collaborating in their endeavor to create Kentucky’s first proper operating clinical command center that will serve the tele-critical care and operational optimization. This will take help from Philips’ acute telehealth platform, eCareManager. The academic medical center is planning a centralized virtual care model that will help in assessing the deterioration of patient in time so that they can take proper steps to initiate procedures and influence progresses.

In April 2020, Lumeris, declared the launching of its Virtual Care Access Package solution that will help payers and providers prevent hospitalizations to fight against the ongoing COVID-19 crisis. The solution integrates various COVID-19 specific models, analytics, and services that are specifically designed to assess the state in which the patient is and how quickly that person requires actions.

Comments

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...